Literature DB >> 11883502

Phage display as a tool for protease ligand discovery.

Andrew E Nixon1.   

Abstract

Proteolytic enzymes have been implicated as the pathological agent in a number of disease states. For this reason proteases are attractive therapeutic targets. Phage display of peptide libraries can be used to identify peptides that may be used either directly as inhibitors or serve as leads in the generation of prodrugs and peptidomimetics.

Mesh:

Substances:

Year:  2002        PMID: 11883502     DOI: 10.2174/1389201023378526

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  5 in total

1.  Enzyme-mediated individual nanoparticle release assay.

Authors:  James R Glass; Janet C Dickerson; David A Schultz
Journal:  Anal Biochem       Date:  2006-03-31       Impact factor: 3.365

2.  Screening of peptide libraries against protective antigen of Bacillus anthracis in a disposable microfluidic cartridge.

Authors:  Joshua M Kogot; Yanting Zhang; Stephen J Moore; Paul Pagano; Dimitra N Stratis-Cullum; David Chang-Yen; Marek Turewicz; Paul M Pellegrino; Andre de Fusco; H Tom Soh; Nancy E Stagliano
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

3.  A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro.

Authors:  Peter Durand Skottrup; Grete Sørensen; Miroslaw Ksiazek; Jan Potempa; Erik Riise
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

4.  The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.

Authors:  Lauren R H Krumpe; Toshiyuki Mori
Journal:  Int J Pept Res Ther       Date:  2006-03-03       Impact factor: 1.931

Review 5.  Plant/Bacterial Virus-Based Drug Discovery, Drug Delivery, and Therapeutics.

Authors:  Esen Sokullu; Hoda Soleymani Abyaneh; Marc A Gauthier
Journal:  Pharmaceutics       Date:  2019-05-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.